First-of-its-kind STARD(3) Inhibitor: In Silico Identification and Biological Evaluation as Anticancer Agent

[Image: see text] STARD3 is a cellular protein that represents an attractive target for cancer therapy, being overexpressed in breast cancer and implied in the development of colorectal, gastric, and prostate cancers. Unfortunately, no STARD3 inhibitor has been identified yet. In this work, an in si...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:ACS Med Chem Lett
Päätekijät: Lapillo, Margherita, Salis, Barbara, Palazzolo, Stefano, Poli, Giulio, Granchi, Carlotta, Minutolo, Filippo, Rotondo, Rossella, Caligiuri, Isabella, Canzonieri, Vincenzo, Tuccinardi, Tiziano, Rizzolio, Flavio
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: American Chemical Society 2019
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC6466518/
https://ncbi.nlm.nih.gov/pubmed/30996782
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1021/acsmedchemlett.8b00509
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia